Trade Summary

5 days ago, Pakola Steve, serving as Chief Medical Officer at Regenxbio Inc. (RGNX), sold 5,124 shares at $10.35 per share, for a total transaction value of $53,033.00. Following this transaction, Pakola Steve now holds 247,926 shares of RGNX.

This sale represents a 2.00% decrease in Pakola Steve's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Tuesday, March 10, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, March 12, 2026, 2 days after the trade was made.

Regenxbio Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.